Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model (Q78103544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

main subject

Pseudomonas aeruginosa

1 reference

A G Felts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

G Giridhar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

D W Grainger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J B Slunt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

415-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Therapeutic efficacy of timentin and augmentin versus silvadene in burn wound infections

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Changing flora in burn and trauma units: experience in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Opsonic activity of sera and blister fluid from severely burned patients evaluated by a chemiluminescence method

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Immediate burn wound excision restores antibody synthesis to bacterial antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Initial management of burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Effects of prophylactic intravenous immunoglobulin-G therapy on humoral and cellular immune components and their functions in burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Effect of thermal injury on the adherence of Candida albicans to murine splenic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Use of intravenous immunoglobulin (IVIG) therapy in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Intravenous immunoglobins (IVIGs) to prevent and treat infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

The use of intravenous immune globulin in immunodeficiency diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Passive and active immunotherapy for experimental pneumococcal pneumonia by polyvalent human immunoglobulin or F(ab')2 fragments administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

1 reference

7 January 2021

The best of times, the worst of times. The global challenge of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Crisis in infectious diseases: time for a new paradigm?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Control of methicillin-resistant Staphylococcus aureus in a pediatric burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Burn and trauma units as sources of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Fear of MRSA--potential for future disaster

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Vancomycin resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Topical immunoglobulin is an effective therapy for parainfluenza type 3 in a cotton rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Prophylactic intravenous immunoglobulin replacement in high-risk burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

Patterns of Staphylococcus aureus colonization, toxin production, immunity and illness in burned children

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900017-0

7 January 2021

10.1016/S0305-4179(99)00017-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10439150%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference